Skip to main content

Table 1 Dietary FA compositions

From: A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet

Ingredient (%)

Control chow

CDAA-HF-T(+)

CDAA-HF-T(−)

C14:0

0.5

0.3

0.8

C16:0

11.4

13.2

26.1

C16:1 n-7

0.7

0.1

0.2

C18:0

1.1

6.0

4.2

C18:1 n-7

1.6

10.6

0.9

C18:1 n-7 t

0.1

7.2

0.0

C18:1 n-9

23.2

32.6

43.0

C18:1 n-9 t

0.1

3.4

0.1

C18:2 n-6

52.1

25.0

23.8

C18:2 n-6 tt

N.D.

0.6

0.0

C18:3 n-3

3.4

0.4

0.4

C18:3 n-6

N.D.

0.2

0.1

C20:0

0.3

0.4

0.4

C20:2 n-6

0.0

0.0

0.0

C20:3 n-6

N.D.

N.D.

N.D.

C20:4 n-6

N.D.

0.0

N.D.

C20:5 n-3

1.2

N.D.

N.D.

C22:5 n-3

0.1

N.D.

N.D.

C22:6 n-3

4.2

N.D.

N.D.

Total

100

100

100

Ingredient (%)

Control chow

CDAA-HF-T(+)

CDAA-HF-T(−)

SFA

13.2

19.9

31.5

MUFA

25.5

43.3

44.0

n-6 PUFA

52.2

25.1

23.9

n-3 PUFA

8.9

0.4

0.4

TFAs

0.2

11.2

0.2

Total

100

100

100

Total fat (g/100 g diet)

Control chow

CDAA-HF-T(+)

CDAA-HF-T(−)

 

4.5

24.5

24.5

  1. ND not detected